GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pathfinder Cell Therapy Inc (OTCPK:PFND) » Definitions » Total Liabilities

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Total Liabilities : $6.77 Mil (As of Sep. 2015)


View and export this data going back to . Start your Free Trial

What is Pathfinder Cell Therapy Total Liabilities?

Pathfinder Cell Therapy's Total Liabilities for the quarter that ended in Sep. 2015 was $6.77 Mil.

Pathfinder Cell Therapy's quarterly Total Liabilities increased from Mar. 2015 ($6.31 Mil) to Jun. 2015 ($6.49 Mil) and increased from Jun. 2015 ($6.49 Mil) to Sep. 2015 ($6.77 Mil).

Pathfinder Cell Therapy's annual Total Liabilities increased from Dec. 2012 ($3.21 Mil) to Dec. 2013 ($4.71 Mil) and increased from Dec. 2013 ($4.71 Mil) to Dec. 2014 ($6.05 Mil).


Pathfinder Cell Therapy Total Liabilities Historical Data

The historical data trend for Pathfinder Cell Therapy's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pathfinder Cell Therapy Total Liabilities Chart

Pathfinder Cell Therapy Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.32 1.35 3.21 4.71 6.05

Pathfinder Cell Therapy Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.72 6.05 6.31 6.49 6.77

Pathfinder Cell Therapy Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Pathfinder Cell Therapy's Total Liabilities for the fiscal year that ended in Dec. 2014 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6.049+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=6.05

Total Liabilities=Total Assets (A: Dec. 2014 )-Total Equity (A: Dec. 2014 )
=0.106--5.943
=6.05

Pathfinder Cell Therapy's Total Liabilities for the quarter that ended in Sep. 2015 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6.769+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=6.77

Total Liabilities=Total Assets (Q: Sep. 2015 )-Total Equity (Q: Sep. 2015 )
=0.039--6.73
=6.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pathfinder Cell Therapy Total Liabilities Related Terms

Thank you for viewing the detailed overview of Pathfinder Cell Therapy's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Pathfinder Cell Therapy (Pathfinder Cell Therapy) Business Description

Traded in Other Exchanges
N/A
Address
12 Bow Street, Cambridge, MA, USA, 02138
Pathfinder Cell Therapy Inc is a regenerative medicine company. It is engaged in developing novel cell-based and related therapies for the treatment of diabetes, renal diseases and medical conditions characterized by organ-specific cell damage. Further, the group has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells ("PCs") themselves being incorporated into the new tissue. Geographically the business activities are functioned through the region of United States.
Executives
John J Alam director 130 WAVERLY STREET, CAMBRIDGE MA 02139
John L Brooks director 100 LOWDER BROOK DRIVE SUITE 2500, WESTWOOD MA 02090

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Headlines

No Headlines